glutathione levels Total and reduced glutathione levels

Crucially, its enhanced metabolic stability and superior bioavailability enable it to readily traverse the blood-brain barrier, surpassing the therapeutic limitations of its parent molecule

BPC-157 is generally well tolerated, but since its not approved as a drug, long-term human safety data is limited

In addition to a medium made of 0.5 ml of DMEM, 10% FBS, 100 U/mL of penicillin, and 100 mg/mL of streptomycin, BPC 157 was added to each well in concentrations of 0 (control group), 0.1, 0.25, and 0.5 ug/mL for 1, 2, and 3 days in a humidified atmosphere

This reclassification has significantly impacted access through legitimate medical channels